Aviation Medication Transparency Act of 2025
Latest Action
Committee on Commerce, Science, and Transportation. Ordered to be reported with an amendment in the nature of a substitute favorably.
Official Summary
Aviation Medication Transparency Act of 2025 This bill directs the Federal Aviation Administration (FAA) to compile, publish, and annually update a list of medications that may be safely prescribed to pilots and air traffic controllers for the purposes of issuing a medical certification. The list must be publicly available on the FAA website and distributed to those seeking a license and medical certification. Currently, the FAA does not have a list of approved medications. However, the FAA does have lists for Aviation Medical Examiners of Do Not Issue medications and Do Not Fly medications.
GovScope Watchdog™
AI Government Intelligence™The Aviation Medication Transparency Act of 2025 requires the Federal Aviation Administration (FAA) to create, publish, and update annually a publicly accessible list of medications that can be safely prescribed to pilots and air traffic controllers for medical certification purposes. This list aims to provide clear guidance to those seeking FAA medical certification, addressing a current gap since the FAA presently only maintains internal lists of medications that are prohibited or restrict flying but does not have an approved medication list for public use.
This bill mandates the FAA to increase transparency by publicly listing medications safe for pilots and air traffic controllers, potentially improving clarity in medical certification processes.
- FAA must compile and publish a list of medications safe for pilots and air traffic controllers annually.
- The list will be publicly available on the FAA website and distributed to license and medical certification applicants.
- Currently, the FAA only maintains internal 'Do Not Issue' and 'Do Not Fly' medication lists for Aviation Medical Examiners, not a public approved medication list.
['Pilots seeking FAA medical certification', 'Air traffic controllers undergoing medical certification', 'Federal Aviation Administration (FAA)', 'Aviation Medical Examiners', 'Aviation industry stakeholders requiring clarity on medication policies']
['The bill does not specify funding or resources for the FAA to develop and maintain the medication list, which may affect implementation.', 'Annual updates require ongoing oversight and medical expertise to ensure accuracy and relevance of the medication list.', 'Potential challenges in balancing transparency with medical privacy and liability considerations.', 'The bill text is not provided, so detailed provisions on enforcement or compliance mechanisms are unknown.']
The bill is currently in process in the Senate and has been favorably reported by the Committee on Commerce, Science, and Transportation with an amendment. It addresses a regulatory transparency gap in FAA medical certification policies, reflecting ongoing efforts to improve aviation safety and regulatory clarity within the transportation policy area.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Improved transparency may lead to better-informed pilots and controllers regarding medication use and medical certification eligibility.', 'Public availability of the medication list could influence prescribing practices by healthcare providers for aviation personnel.', 'Potential reduction in certification delays or disputes related to medication use due to clearer guidance.']
The absence of the full bill text limits detailed analysis of enforcement, compliance, and funding provisions. Transparency improvements depend on FAA's capacity to maintain and update the medication list effectively. Oversight mechanisms for ensuring the list's accuracy and relevance are not detailed, which are critical for sustained policy impact.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.